Abstract:Photodynamic therapy (PDT) has been increasingly studied in cancer treatment, and several factors have been identified to limit the PDT therapeutic efficiency. Taking Bcl-2 protein as an example, its overexpressing in cancer cells could strengthen the antioxidant and antiapoptotic capability of the cells, making PDT less effective in cancer cell treatment. To address this issue, we developed an engineered living system by integrating an aggregation-induced emission photosensitizer (AIE PS) with bioactive mitochondria (Mito-AIEgen-lipid) for enhanced PDT. The AIE PS engineered mitochondria could not only change the energetic metabolism of cancer cells from aerobic glycolysis to normal oxide phosphorylation for cancer cell growth inhibition but also activate the apoptotic pathway and reduce the expression of antiapoptotic protein Bcl-2. This specific organelle-based living system holds great promise to enhance the therapeutic efficiency of PDT by integrating the advantages of synthetic organic small molecules with biological components.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.nanolett.0c02778?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.nanolett.0c02778</a>.Experimental details, fluorescence images, correlation between the protein concentration of the Mito-enriched fraction and the number of isolated mitochondria, confocal microscopic images of Mito-AIEgen-lipid, flow cytometry data of 4T1 cell after incubation with AIEgen-lipid, and the localization of AIEgen-lipid (40 μM) and Mito-AIEgen-lipid (<a class="ext-link" href="/doi/suppl/10.1021/acs.nanolett.0c02778/suppl_file/nl0c02778_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

What problem does this paper attempt to address?

This paper attempts to solve the problem of efficiency limitations in photodynamic therapy (PDT) in cancer treatment. Specifically, the paper focuses on how the over - expressed Bcl - 2 protein in cancer cells enhances antioxidant and anti - apoptotic abilities, thereby reducing the efficacy of PDT. To overcome this problem, the research team has developed a new engineered living system by combining aggregation - induced emission photosensitizers (AIE PS) with bioactive mitochondria (Mito - AIEgen - lipid) to enhance the effect of PDT. ### Main Objectives: 1. **Alter Energy Metabolism**: By introducing healthy mitochondria into cancer cells, the energy metabolism of cancer cells is changed from inefficient aerobic glycolysis to normal oxidative phosphorylation (OXPHOS), thereby inhibiting the growth of cancer cells. 2. **Activate Apoptotic Pathways**: Reduce the expression of the anti - apoptotic protein Bcl - 2 and increase the expression of pro - apoptotic factors (such as cleaved - caspase3) to re - activate the apoptotic pathway. 3. **Enhance PDT Efficacy**: Through the above - mentioned biological regulation, significantly improve the killing effect of PDT on cancer cells. ### Key Technologies: - **Synthesis and Modification of AIE PS**: Synthesize photosensitizers (AIEgen - lipid) with aggregation - induced emission characteristics and label them on the mitochondrial membrane through hydrophobic interactions. - **Mitochondrial Extraction and Modification**: Extract healthy mitochondria from normal mouse fibroblast cells (NIH3T3) and modify them with AIEgen - lipid. - **Cell Internalization and Functional Verification**: Introduce the modified mitochondria into breast tumor cells (4T1) and verify their effects on cell metabolism and apoptotic pathways. ### Experimental Results: - **Alteration of Metabolic Pathways**: The modified mitochondria can effectively change the energy metabolic pathways of cancer cells, reducing aerobic glycolysis and increasing oxidative phosphorylation. - **Activation of Apoptotic Pathways**: Significantly reduce the expression of Bcl - 2 and increase the expression of cleaved - caspase3, thereby activating the apoptotic pathway. - **Enhancement of PDT Efficacy**: Under light conditions, Mito - AIEgen - lipid significantly enhances the killing effect of PDT on cancer cells. ### Conclusion: By combining healthy mitochondria with AIE PS, the research team has successfully developed a new strategy, which not only changes the energy metabolic pathways of cancer cells but also activates the apoptotic pathways, thereby significantly improving the therapeutic effect of PDT. This method provides new ideas for enhancing the efficacy of traditional cancer treatment methods.

Engineering Living Mitochondria with AIE Photosensitizer for Synergistic Cancer Cell Ablation

Unusual Electron Donor-Acceptor Sequenced NIR AIEgen for Highly Efficient Mitochondria-Targeted Cancer Cell Photodynamic Therapy.

Boost Highly Efficient Singlet Oxygen Generation and Accelerate Cancer Cell Apoptosis for Photodynamic Therapy by Logically Designed Mitochondria Targeted Near-Infrared AIEgens

Boosting the Photodynamic Therapy Efficiency with a Mitochondria-Targeted Nanophotosensitizer

Mitochondrial targeted AIEgen phototheranostics for bypassing immune barrier via encumbering mitochondria functions

Reversing Multidrug Resistance by Inducing Mitochondrial Dysfunction for Enhanced Chemo-Photodynamic Therapy in Tumor

Molecular Engineering of Plasma Membrane and Mitochondria Dual‐Targeted NIR‐II AIE Photosensitizer Evoking Synergetic Pyroptosis and Apoptosis

A Ph-Activatable Nanoparticle for Dual-Stage Precisely Mitochondria-Targeted Photodynamic Anticancer Therapy.

AIEgens/Mitochondria Nanohybrids as Bioactive Microwave Sensitizers for Non‐Thermal Microwave Cancer Therapy

AIEgen-Based Bionic Nanozymes for the Interventional Photodynamic Therapy-Based Treatment of Orthotopic Colon Cancer

The AIE‐Active Dual‐Cationic Molecular Engineering: Synergistic Effect of Dark Toxicity and Phototoxicity for Anticancer Therapy

Alkyl chain length-regulated in situ intelligent nano-assemblies with AIE-active photosensitizers for photodynamic cancer therapy

Biotin Receptor and Mitochondria Dual Targeted AIE Photosensitizer for Fluorescence Imaging Guided Photodynamic Anticancer Therapy

A simple mitochondrial targeting AIEgen for image-guided two-photon excited photodynamic therapy.

Self-Monitoring the Endo-Lysosomal Escape and Near-Infrared-Activated Mitophagy To Guide Synergistic Type-I Photodynamic and Photothermal Therapy

Molecular Engineering to Boost AIE‐Active Free Radical Photogenerators and Enable High‐Performance Photodynamic Therapy under Hypoxia

Molecular Engineering of Efficient Singlet Oxygen Generators with Near‐Infrared AIE Features for Mitochondrial Targeted Photodynamic Therapy

Boosting Theranostic Performance of AIEgens Using Nanocatalyzer for Robust Cancer Immunotherapy

Efficient NIR-II Type-I AIE Photosensitizer for Mitochondria-Targeted Photodynamic Therapy through Synergistic Apoptosis-Ferroptosis

Engineered cyanobacteria-Fe3O4 hybrid system as oxygen generator and photosensitizer production factory for synergistic cancer PDT-immunotherapy

Molecular Engineering of High-Performance Aggregation-Induced Emission Photosensitizers to Boost Cancer Theranostics Mediated by Acid-Triggered Nucleus-Targeted Nanovectors